|Bid||0.3500 x 0|
|Ask||0.3600 x 0|
|Day's range||0.3450 - 0.3600|
|52-week range||0.1800 - 0.6800|
|Beta (5Y monthly)||0.02|
|PE ratio (TTM)||N/A|
|Earnings date||27 Aug 2018 - 31 Aug 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...
Paul Anderson is the CEO of Orthocell Limited (ASX:OCC). This analysis aims first to contrast CEO compensation with...